FIELD: medicine.
SUBSTANCE: invention refers to medicine, cardiology, namely to atherosclerosis diagnostics. Substance of the invention involves detection of SS and FS phenotypes of C'3 locus, and if SS phenotype of C'3 locus found, genetic predisposition to atherosclerotic processes is ascertained, while the presence of FS phenotype of C'3 locus shows genetic predisposition to containment of atherosclerotic processes.
EFFECT: higher accuracy.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING PREDISPOSITION TO ATHEROSCLEROSIS DISEASE BASED ON DETERMINING EXPRESSION OF GENES INVOLVED IN ACCUMULATION OF CHOLESTEROL | 2018 |
|
RU2698092C1 |
| METHOD FOR LIABILITY TO DEVELOPMENT OF ATHEROSCLEROSIS IN MIDDLE-AGED MEN | 2020 |
|
RU2738975C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPMENT OF ATHEROSCLEROSIS IN MINERS WITH ANTHRACOSILICOSIS | 2015 |
|
RU2595086C1 |
| METHOD OF MYOCARDIUM INFARCTION DIAGNOSIS | 1993 |
|
RU2079134C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPING ATHEROSCLEROSIS IN MINERS WITH CHRONIC DUST BRONCHITIS | 2018 |
|
RU2690393C1 |
| METHOD FOR EVALUATING RISK OF CLINICAL COMPLICATIONS OF ATHEROSCLEROSIS | 2011 |
|
RU2498307C2 |
| DIAGNOSTIC TECHNIQUE FOR DISPOSITION TO ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASES BY PERIPHERAL BLOOD INTERLEUKIN-10-PRODUCING LYMPHOCYTE COUNT | 2014 |
|
RU2575791C1 |
| DIAGNOSTIC TECHNIQUE FOR PREDISPOSITION TO ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE AS SHOWN BY PERIPHERAL BLOOD INTERLEUKIN-10 AND INTERLEUKIN-17 CONCENTRATIONS | 2014 |
|
RU2566288C1 |
| METHOD FOR DETECTION OF GENETIC PREDISPOSITION TO DEVELOPING MYOCARIAL INFARCTION IN INDIVIDUALS WITH NO CLINICAL IMPLICATIONS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2469096C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF VARIOUS DEGREES OF SEVERITY OF CHRONIC HEART FAILURE | 2021 |
|
RU2772359C1 |
